HomeCompareYASKF vs JNJ

YASKF vs JNJ: Dividend Comparison 2026

YASKF yields 1.40% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $1.2K in total portfolio value· pulled ahead in Year 10
10 years
YASKF
YASKF
● Live price
1.40%
Share price
$28.95
Annual div
$0.40
5Y div CAGR
27.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$2,141.09
Full YASKF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — YASKF vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYASKFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YASKF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YASKF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YASKF
Annual income on $10K today (after 15% tax)
$118.88/yr
After 10yr DRIP, annual income (after tax)
$1,819.93/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $2,217.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YASKF + JNJ for your $10,000?

YASKF: 50%JNJ: 50%
100% JNJ50/50100% YASKF
Portfolio after 10yr
$29.9K
Annual income
$3,445.48/yr
Blended yield
11.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

YASKF
No analyst data
Altman Z
3.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YASKF buys
0
JNJ buys
0
No recent congressional trades found for YASKF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYASKFJNJ
Forward yield1.40%2.14%
Annual dividend / share$0.40$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR27.2%28%
Portfolio after 10y$29.3K$30.5K
Annual income after 10y$2,141.09$4,749.88
Total dividends collected$8.0K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YASKF vs JNJ ($10,000, DRIP)

YearYASKF PortfolioYASKF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,878$177.90$10,594$274.49+$284.00YASKF
2$11,869$230.05$11,294$360.69+$575.00YASKF
3$12,999$298.40$12,133$476.91+$866.00YASKF
4$14,297$388.48$13,156$635.42+$1.1KYASKF
5$15,806$507.95$14,432$854.61+$1.4KYASKF
6$17,580$667.57$16,056$1,162.76+$1.5KYASKF
7$19,693$882.67$18,175$1,604.53+$1.5KYASKF
8$22,247$1,175.44$21,009$2,252.68+$1.2KYASKF
9$25,383$1,578.56$24,911$3,229.73+$472.00YASKF
10← crossover$29,301$2,141.09$30,458$4,749.88$1.2KJNJ

YASKF vs JNJ: Complete Analysis 2026

YASKFStock

YASKAWA Electric Corporation engages in motion control, robotics, system engineering, and other businesses worldwide. It manufactures and sells various AC drives, including general purpose AC drives, specific purpose AC drives, AC Drive for systems, regenerative energy saving units, and PM motors for use in household appliances, such as air conditioners and refrigerators; social infrastructures comprising elevators, escalators, trains, cranes, fans, and pumps; and factories that manufacture printing machinery, textile machinery, rubber machinery, and other materials. The company also offers rotary servo motors, direct drive servo motors, linear motors/linear sliders, machine controllers, positioning sensor encoders, and servo amplifiers for use in industrial robots, semiconductor manufacturing apparatus, machine tools, flat panel display manufacturing equipment, and metal working machines; and arc and spot welding, handling/assembling, collaborative, biomedical, palletizing, press handling, sealing/cutting/laser machining, deburring, painting, glass substrates transfer, and semiconductor wafer transfer robots for use in semiconductor wafer conveyance, arc welding, spot welding, handling, assembly, and palletizing applications. In addition, it provides industrial system electrical products, such as medium-voltage AC drives, system use AC drives, and system controllers for use in iron and steel systems, water and wastewater treatment, crane, and paper-making/film/port cargo handling/fiber/printing applications. Further, the company offers equipment for energy saving and creation comprising PV inverters, systems for large wind turbines, control equipment for small-scale power generation, and motor drive systems for use in photovoltaic power generation, large-scale wind power generation, small-scale power generation, and electric vehicles. YASKAWA Electric Corporation was founded in 1915 and is headquartered in Kitakyushu, Japan.

Full YASKF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this YASKF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YASKF vs SCHDYASKF vs JEPIYASKF vs OYASKF vs KOYASKF vs MAINYASKF vs ABBVYASKF vs MRKYASKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.